ASSESSMENT OF "CA²⁺-ANTAGONIST" EFFECTS OF DRUGS IN K⁺-DEPOLARIZED SMOOTH MUSCLE: DIFFERENTIATION OF ANTAGONIST SUBGROUPSSPEDDING M.1982; NAUNYN-SCHMIEDEBERG ARCH. PHARMACOL.; ISSN 0369-5565; DEU; DA. 1982; VOL. 318; NO 3; PP. 234-240; BIBL. 39 REF.Article

EFFECTS OF METOCLOPRAMIDE AND ISOPRENALINE IN THE RAT VAS DEFERENS; INTERACTIONS WITH ALPHA -ADRENOCEPTORSSPEDDING M.1980; BR. J. PHARMACOL.; ISSN 0007-1188; GBR; DA. 1980; VOL. 71; NO 1; PP. 113-120; BIBL. 2 P.Article

DIFFERENCES BETWEEN THE EFFECTS OF CALCIUM ANTAGONISTS IN THE PITHED RAT PREPARATIONSPEDDING M.1982; JOURNAL OF CARDIOVASCULAR PHARMACOLOGY; ISSN 0160-2446; USA; DA. 1982; VOL. 4; NO 6; PP. 973-979; BIBL. 42 REF.Article

Functional interactions of calcium-antagonists in K⁺-depolarized smooth muscleSPEDDING, M.British journal of pharmacology. 1983, Vol 80, Num 3, pp 485-488, issn 0007-1188Article

Competitive interactions between bay K 8644 and nifedipine in K⁺ depolarized smooth muscle: a passive role for Ca²⁺?SPEDDING, M.Naunyn-Schmiedeberg's archives of pharmacology. 1985, Vol 328, Num 4, pp 464-466, issn 0028-1298Article

STEREOSPECIFIC BLOCKADE OF ALPHA ₂-ADRENOCEPTORS BY (+)-BUTACLAMOL: OMPLICATIONS FOR THE CHARACTERIZATION OF DOPAMINE RECEPTORSSPEDDING M; BERG C.1982; J. PHARM. PHARMACOL.; ISSN 0022-3573; GBR; DA. 1982; VOL. 34; NO 1; PP. 56-58; BIBL. 19 REF.Article

THE MECHANISM OF THE RELAXANT EFFECT OF 2-2'-PYRIDYLISATOGEN ON THE ISOLATED TAENIA OF THE GUINEA-PIG CAECUMSPEDDING M; WEETMAN DF.1978; BRIT. J. PHARMACOL.; GBR; DA. 1978; VOL. 63; NO 4; PP. 659-664; BIBL. 23 REF.Article

Interaction of phorbol esters with Ca²⁺ channels in smooth muscleSPEDDING, M.British journal of pharmacology. 1987, Vol 91, Num 2, pp 377-384, issn 0007-1188Article

THE PROBLEMS ASSOCIATED WITH THE USE OF 2,2'-PYRIDYLISATAGEN TOSYLATE IN EVALUATING THE ALLEGEDLY PURINERGIC INNERVATION OF PERIPHERAL ORGANS.SPEDDING M; WEETMAN DF.1978; J. PHARM. PHARMACOL.; G.B.; DA. 1978; VOL. 30; NO 5; PP. 335-336; BIBL. 8 REF.Article

Nouvelles perspectives pour le traitement des accidents vasculaires cérébraux? = New perspectives for the treatment of cerebral vascular accidentsSPEDDING, M.Circulation et métabolisme du cerveau. 1994, Vol 11, Num 2, pp 189-199, issn 0264-6900Article

Activators and inactivators of Ca⁺⁺ channels: new perspectivesSPEDDING, M.Journal de pharmacologie. 1985, Vol 16, Num 4, pp 319-343, issn 0021-793XArticle

IDENTIFICATION OF SEPARATE RECEPTORS FOR ADENOSINE AND ADENOSINE 5'-TRIPHOSPHATE IN CAUSING RELAXATIONS OF THE ISOLATED TAENIA OF THE GUINEA-PIG CAECUM.SPEDDING M; WEETMAN DF.1976; BRIT. J. PHARMACOL.; G.B.; DA. 1976; VOL. 57; NO 2; PP. 305-310; BIBL. 15 REF.Article

VASODILATION BY MEDROXALOL MEDIATED BY BETA ₂-ADRENERGIC RECEPTOR STIMULATIONDAGE RC; CHIH PENG HSIEH; SPEDDING M et al.1983; JOURNAL OF CARDIOVASCULAR PHARMACOLOGY; ISSN 0160-2446; USA; DA. 1983; VOL. 5; NO 1; PP. 143-150; BIBL. 15 REF.Article

Differential effects of non-peptidic tachykinin receptor antagonists on Ca²⁺ channelsLOMBET, A; SPEDDING, M.European journal of pharmacology. Molecular pharmacology section. 1994, Vol 267, Num 1, pp 113-115, issn 0922-4106Article

A functional correlate for the dihydropyridine binding site in rat brainMIDDLEMISS, D. N; SPEDDING, M.Nature (London). 1985, Vol 314, Num 6006, pp 94-96, issn 0028-0836Article

Drugs in sport : a scientist-athlete's perspective: from ambition to neurochemistry : Drugs in sportSPEDDING, M; SPEDDING, C.British journal of pharmacology. 2008, Vol 154, Num 3, pp 496-501, issn 0007-1188, 6 p.Article

Differential effects of calcium channel antagonists on histamine and pentagstrin-stimulated gastric acid secretion in the ratBOUCLIER, M; SPEDDING, M.Collection sécurité. 1985, Vol 16, Num 6, pp 491-495, issn 0538-4818Article

Interactions between a calcium channel agonist, Bay K 8644, and calcium antagonists differentiate calcium antagonist subgroups in K⁺-depolarized smooth muscleSPEDDING, M; BERG, C.Naunyn-Schmiedeberg's archives of pharmacology. 1984, Vol 328, Num 1, pp 69-75, issn 0028-1298Article

calcium antagonists: a class of drugs with a bright future. I: Cellular calcium homeostasis and calcium as a coupling messengerCAVERO, I; SPEDDING, M.Life sciences (1973). 1983, Vol 33, Num 26, pp 2571-2581, issn 0024-3205Article

Voltage-dependent calcium channels : structures and drug-binding sites : 640th meeting Heriot-Watt, Edinburgh, 4-6 September 1991SPEDDING, M; KENNY, B.Biochemical Society transactions. 1992, Vol 20, Num 1, pp 147-153, issn 0300-5127Conference Paper

Calcium antagonist properties of diclofurime isomers. II: Molecular aspects: allosteric interactions with dihydropyridine recognition sitesMIR, A. K; SPEDDING, M.Journal of cardiovascular pharmacology. 1987, Vol 9, Num 4, pp 469-477, issn 0160-2446Article

Calcium antagonists: a class of drugs with a bright future. II: Determination of basic pharmacological propertiesSPEDDING, M; CAVERO, I.Life sciences (1973). 1984, Vol 35, Num 6, pp 575-587, issn 0024-3205Article

Direct activation of Ca²⁺ channels by palmitoyl carnitine, a putative endogenous ligandSPEDDING, M; MIR, A. K.British journal of pharmacology. 1987, Vol 92, Num 2, pp 457-468, issn 0007-1188Article

Antagonism of Ca²⁺-induced contractions of K⁺-depolarized smooth muscle by local anaestheticsSPEDDING, M; BERG, C.European journal of pharmacology. 1985, Vol 108, Num 2, pp 143-150, issn 0014-2999Article

Classification of calcium channels and calcium antagonists : progress reportSPEDDING, M; PAOLETTI, R.Cardiovascular drugs and therapy. 1992, Vol 6, Num 1, pp 35-39, issn 0920-3206Article